This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
News
February workshops filling up fast
Our workshops are an invaluable opportunity to experience F Care Systems products in a real-world treatment setting. Our 23 February session is already booked, but we still have space available on 12 April in Cologne. Don’t miss out!
Rafaelo Masterclasses
Recently, two training sessions on the Rafaelo method were held in Delhi and Mumbai, attended by enthusiastic experts and students.
Join us at Medica 2023
We are pleased to inform you about our participation at Medica, the prominent trade fair for the medical industry, scheduled from November 13th to November 16th in Düsseldorf.
New Fistura Pack now available!
A convenient all-inclusive kit for anal fistula treatment.
Rafaelo® meets expectations of a minimally invasive technique.
Researchers in a French prospective multicentre study concluded that RFA (Rafaelo®) is associated with an improvement in quality of life and symptoms with a good safety profile.
FDA Approval for HPR45i electrode
F Care Systems announces FDA Approval of HPR45i electrosurgical electrode.
F Care Systems to attend annual proctology conference
Our event calendar is filling up! Next stop: the German Society for Coloproctology’s 45th annual conference, to be held on 16-18 March in Munich. See you there?
New release of the Sphera
F Care Systems is proud to announce the release of the Sphera, a new rounded probe designed for surface coagulation of Grade I and II internal haemorrhoids.
Rafaelo® workshop
Our next Rafaelo® workshop is scheduled for 21 April in…
First multicentre prospective study of Fistura® released
Researchers in France found that radiofrequency ablation of fistula-in-ano resulted in practically no post-treatment pain or risk of incontinence, both of which represent potential advantages over surgical fistulotomy.
Rafaelo® study confirms effective and lasting results
A five-year retrospective study of radiofrequency haemorrhoid ablation concluded that Rafaelo® not only carried minimal risk of pain and complications, but provided effective, lasting results.